Smith & Nephew names Julie Brown its new finance chief
Smith & Nephew (FTSE:SN, NYSE:SNN) named Julie Brown as CFO and board director, effective February 2013, succeeding former CFO Adrian Hennah, who resigned his post to become a CFO of consumer health & hygiene company Reckitt Benckiser Group.
Brown most recently worked at AstraZeneca PLC as VP group finance and interim CFO, prior to which, she worked in senior financial and management positions at the company.
"Julie is an outstanding leader who brings to Smith & Nephew exceptional financial expertise and a deep knowledge of the healthcare market," CEO Olivier Bohuon said in prepared remarks.
"Her ability to build teams and her broad experience working across geographies and within senior commercial roles will undoubtedly enable her to be a strong business partner," he added. "I look forward to working closely together as we continue to reshape Smith & Nephew for future success."
Read more
Accuray’s executive VP & COO "pursues other interests"
Chris Raanes stepped down from his role as Accuray’s (NSDQ:ARAY) executive VP & COO to “pursue other interests”, according to the regulatory filing.
Read more
Covidien board director resigns
Timothy Donahue, the lead director of the Covidien’s (NYSE:COV) board of directors, resigned from his role. The decision was not a result of disagreement between Donahue and the company or the management, according to the regulatory filings.
Donahue is a former chairman of Sprint Nextel Corporation and is currently director of Eastman Kodak Company and Tyco International.
Read more
Syneron Medical’s board chairman dies
Syneron Medical’s (NSDQ:ELOS) founder & board chairman Marshall Butler died. He was 85.
Butler joined the board in 2003. He was was co- founder & chairman of First Israel Mezzanine Investors Fund and Israeli Infinity VC Fund, as well as a director of Tadiran Telecommunications, Shellcase, and Galil Medical.
Butler in 1998 received the Israeli Prime Minister’s award for his contribution to Israeli industry.
Read more
